Moderna Overview
Moderna Target Price
Analysts' average 12-month price target for Moderna is $110.
Get informed when a big investor buys or sells
+ FollowShare Price
$143.97
Average Target Price
$109.15
24.2% downside
24.2% downside13 analysts in the last 4 months
High: $245 | Low: $25
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-03 | UBS | $81 | 43.7% downside |  |
| 2026-08-28 | Argus ResearchJohn Eade | $180 |  25% upside | |
| 2026-08-24 | BarclaysEliana Merle | $125 | 13.2% downside | |
| 2026-08-20 | UBSMichael Yee | $150 | 4.2% upside | |
| 2026-08-19 | Goldman Sachs | $120 | 16.6% downside | |
| 2026-08-19 | RBC CapitalLuca Issi | $130 | 9.7% downside | |
| 2026-08-19 | Loop Capital MarketsLeah Rush Cann | $135 | 6.2% downside | |
| 2026-08-19 | D.A. DavidsonMichael Baker | $245 | 70.2% upside | |
| 2026-07-21 | Goldman Sachs | $67 | 53.5% downside | |
| 2026-07-20 | Wolfe ResearchAlexandria Hammond | $25 | 82.6% downside | |
| 2026-07-08 | Morgan Stanley | $39 | 72.9% downside | |
| 2026-07-07 | RBC Capital | $45 | 68.7% downside | |
| 2026-06-26 | Piper Sandler | $77 | 46.5% downside | |
| 2026-05-04 | UBS | $45 | 68.7% downside | |
| 2026-05-04 | RBC CapitalLuca Issi | $38 | 73.6% downside | |
| 2026-05-01 | Goldman Sachs | $49 | 66% downside | |
| 2026-05-01 | Morgan Stanley | $33 | 77.1% downside | |
| 2026-03-03 | JefferiesAndrew Tsai | $37 | 74.3% downside | |
| 2026-02-17 | RBC CapitalLuca Issi | $30 | 79.2% downside | |
| 2026-02-17 | Evercore ISICory Kasimov | $35 | 75.7% downside | |
| 2026-02-17 | Bernstein | $45 | 68.7% downside | |
| 2026-02-16 | UBS | $36 | 75% downside | |
| 2026-02-16 | Morgan Stanley | $30 | 79.2% downside | |
| 2026-01-06 | UBS | $34 | 76.4% downside | |
| 2025-12-12 | Morgan Stanley | $28 | 80.6% downside | |
| 2025-12-12 | Jefferies | $30 | 79.2% downside | |
| 2025-11-21 | RBC CapitalLuca Issi | $25 | 82.6% downside | |
| 2025-11-21 | UBS | $18 | 87.5% downside | |
| 2025-11-21 | Piper Sandler | $63 | 56.2% downside | |
| 2025-11-20 | Wolfe Research | $17 | 88.2% downside | |
| 2025-11-17 | Berenberg Bank | $28 | 80.6% downside | |
| 2025-10-23 | UBS | $40 | 72.2% downside | |
| 2025-08-22 | Leerink Partners | $15 | 89.6% downside | |
| 2025-08-01 | Morgan StanleyMatthew Harrison | $32 | 77.8% downside | |
| 2025-08-01 | CitigroupGeoff Meacham | $40 | 72.2% downside | |
| 2025-08-01 | Evercore ISICory Kasimov | $32 | 77.8% downside | |
| 2025-08-01 | J.P. MorganJessica Fye | $26 | 81.9% downside | |
| 2025-02-14 | J.P. MorganJessica Fye | $45 | 68.7% downside | |
| 2025-02-14 | Evercore ISICory Kaimov | $50 | 65.3% downside | |
| 2024-11-18 | Piper SandlerEdward Tenthoff | $69 | 52.1% downside | |
| 2024-11-18 | HSBCYifeng Liu | $58 | 59.7% downside | |
| 2024-10-17 | BernsteinCourtney Breen | $55 | 61.8% downside | |
| 2024-10-14 | JefferiesMichael Yee | $55 | 61.8% downside | |
| 2024-09-13 | Piper SandlerEdward Tenthoff | $115 | 20.1% downside | |
| 2024-09-13 | RBC CapitalLuca Issi | $75 | 47.9% downside | |
| 2024-09-13 | Loop Capital MarketsLeah Rush Cann | $238 | 65.3% upside | |
| 2024-09-12 | JefferiesMichael Yee | $65 | 54.9% downside | |
| 2024-09-12 | Evercore ISICory Kasimov | $105 | 27.1% downside | |
| 2024-09-12 | Morgan StanleyMatthew Harrison | $94 | 34.7% downside | |
| 2024-09-12 | JefferiesMichael Yee | $120 | 16.6% downside | |